
When EJ Sablan, 22, played for the Father Duenas Memorial School Friars soccer team, he was one of the best strikers the school had ever produced. After the 2021 season, during which he led the Friars to a championship, he was named the Independent Interscholastic Athletic Association of Guam (IIAAG) most valuable player. Soon after earning the IIAAG MVP title, Sablan and his family relocated to Puyallup, Washington, where he joined the Emerald Ridge High School Jaguars boys soccer team. As a Jaguar, his role shifted. He was tasked with playing in the backfield, focusing on keeping the ball out of his team’s net - a role he excelled in. After a standout 2023 season as a defender, Sablan earned a spot on the All-South Puget Sound first team. A different school. A different position. The same results. Sablan, no matter the situation, environment or position, continued to make a name for himself. Now, about a year and a half later, Sablan’s determined play and hard work have earned him recognition at the next level. Sablan, who plays midfielder for the Linfield College Wildcats in McMinnville, Oregon, has been named to the All-Northwest Conference (NWC) second team. “I am blessed to be able to perform at the rate that I am. The endless support of God, my family, my teammates and coaches is what keeps me going and inspired to perform well throughout the season,” Sablan said. “Getting nominated for All-NWC second team is just the beginning of my journey. Although I am grateful, I am not satisfied, as I want to achieve bigger and better things.” Sablan told The Guam Daily Post that he enjoys being a midfielder, a position where he can make the greatest difference and showcase his skills as both a defender and an offensive playmaker. “I do enjoy being a midfielder. It gives me the opportunity to compete in the middle of the field, where, in my opinion, games are won,” he said. “I am not too eager to be a striker because, as a midfielder, I get to express myself - finding opportunities to score but also assisting my teammates and getting everyone involved.” Midway through the 2024 season, during a game against the University of Puget Sound Loggers, Sablan found his footing and delivered a breakout performance. Although Linfield trailed 3-0 and eventually lost 3-2, Sablan scored both of the Wildcats’ goals. “This was one of the best experiences I’ve had in my collegiate career,” Sablan said. “The endless fight my team showed is what makes it one of my proudest moments in my Linfield career.” Over the two years Sablan has played for the Wildcats - an NCAA Division III team in the Northwest Conference - the team has recorded an 8-27-5 record. Despite being part of a struggling program, Sablan remains positive and optimistic. "My experience with Linfield soccer has been nothing but good,” he said. “Although the results aren’t what we wanted or expected, I’m just truly blessed to be able to play the sport I love and continue my journey. Every time I step on the field, I’m one step closer to playing professionally and giving back to the community that raised me.”
Heavy travel day starts with brief grounding of all American Airlines flightsMANHASSET, N.Y.--(BUSINESS WIRE)--Dec 24, 2024-- Nearing five years since the beginning of the coronavirus disease 2019 ( COVID-19 ) pandemic, scientists continue to uncover the risk factors of blood clots and potential death for hospitalized and recently discharged patients with COVID-19. A new international study reveals that therapeutic doses of the common blood thinner heparin could significantly improve the survival rate of hospitalized patients with COVID-19. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241224296621/en/ This analysis was designed to resolve conflicting findings from earlier research on blood thinner dosages for COVID-19 and included HEP-COVID, a trial led by Dr. Alex C. Spyropoulos. (Credit: Feinstein Institutes). The comprehensive analysis of 22 clinical trials, 11,000 patients from 21 countries, coordinated by the World Health Organization (WHO), was published today in Annals of Internal Medicine . The analysis was designed to resolve conflicting findings from earlier research on blood thinner dosages for COVID-19 and included HEP-COVID, a trial led by Alex C. Spyropoulos, MD, professor in the Institute of Health System Science at the Feinstein Institutes for Medical Research . HEP-COVID found that giving therapeutic doses of heparin could significantly impact patient outcomes. “Our findings provide crucial guidance for doctors treating hospitalized patients with COVID-19,” said Dr. Spyropoulos. “While blood thinners are already a standard part of care, this study provides evidence that giving therapeutic doses of heparin could significantly impact patient outcomes, including mortality, thromboembolic disease, and disease progression with need for higher level of supportive care. It's a delicate balance between preventing life-threatening clots and minimizing bleeding risks, highlighting the need for personalized treatment strategies based on each patient's unique situation. These results are relevant beyond the COVID-19 pandemic because they provide guidance on managing anticoagulation for patients hospitalized with viral respiratory illnesses and future pandemics.” Researchers investigated three dosage levels of heparin-based blood thinners commonly used in hospital settings— a standard low or preventative dose, an intermediate dose and a high therapeutic dose — which revealed that patients receiving the higher therapeutic dose had a 23 percent lower risk of death within 28 days compared to patients receiving the lower-dosed thinners. These results mostly reflected patients who were in hospital wards but not in intensive care settings. However, the study also highlighted that higher doses of blood thinners were linked to increased risk of major bleeding. “Blood clots are a dangerous complication in hospitalized patients with COVID-19,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research. “These important new findings give guidance for therapeutic protocols to reduce morbidity and mortality.” The research was a prospective meta-analysis, a type of study that combines data from multiple clinical trials to provide a more complete understanding of a treatment's effects. This particular meta-analysis was global in scope and designed in collaboration with researchers from the individual trials before the results of those trials were known, ensuring a more unbiased, comprehensive, and definitive assessment. Dr. Spyropoulos is a world-renowned expert in blood clots who has collaborated with researchers across the globe, particularly during the pandemic, to study clots in patients with COVID-19. Last year he published his research surrounding the PREVENT-HD clinical trial , which studied the efficacy of rivaroxaban – a commonly used prophylactic medication – in preventing blood clots, hospitalizations and death. About the Feinstein Institutes The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn . View source version on businesswire.com : https://www.businesswire.com/news/home/20241224296621/en/ CONTACT: Julianne Mosher Allen 516-880-4824 jmosherallen@northwell.edu KEYWORD: NEW YORK UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: COVID-19 RESEARCH NURSING HOSPITALS CLINICAL TRIALS PRACTICE MANAGEMENT MANAGED CARE PHARMACEUTICAL HEALTH SCIENCE SOURCE: Feinstein Institutes for Medical Research Copyright Business Wire 2024. PUB: 12/24/2024 10:29 AM/DISC: 12/24/2024 10:27 AM http://www.businesswire.com/news/home/20241224296621/enThis week in Southwest Washington fishing, the tributaries are beginning to crowd with anglers chasing early steelhead pushing up rivers in droves. Seth Kolshinski Others are still chasing the few coho still around in some systems, but those will likely to be gone in the next few days. Razor clamming has been approved this week, and Merwin remains very low, although rising slowly, with Yale taking up the slack for anglers looking for their kokanee. As always, remember to verify regulations before fishing any body of water and always wear a life jacket. The Lewis is flowing around 4,400 this week with the only change coming on Wednesday when they dropped flows to check carcass counts along the banks of a lower river. Steelhead are just starting to return and last weekend the locals knew it as the banks of Cedar Creek were lined with anglers chasing early chrome. I talked with several anglers who made the trip there, and while none had any luck, a handful of anglers did pull in bright steelhead as well as some colored-up coho. I talked with Kurtis Youngren, who drifted the Kalama last week, although he didn’t specify what day. He managed to hook one early steelhead which is fantastic, as we usually don’t start seeing catches until around January. Besides Kurtis, I talked with a few other anglers who said the banks were packed last weekend with almost every hole either having someone already in it or someone showing up while they were fishing. Nobody else had any positive reports besides Kurtis. Not much is happening on the Cowlitz right now as the run just hasn’t arrived in any sort of numbers. That isn’t to say there aren’t a few around to catch but it’ll be a grind. Tacoma Power recovered the first two of the year. Angler pressure has been very low this week and I can’t imagine it getting much higher until the steelhead start screaming upriver. I talked with one plunker who had the entire beach to himself with not as much as a trout bite all day long. I drifted the river with good friend Owen Corbett and a reader named Andy in his raft on Sunday. It was a fantastic day. Both Owen and Andy hooked a steelhead with Owen's being a nice 7 or 8-pounder and Andy’s being a small hatchery half-pounder we released. I got several reports of that Sunday being a fantastic day for a lot of anglers leaving with steelhead, which isn’t surprising as the banks were insanely packed with anglers with almost every bank-accessible spot filled. We talked to the plunkers in the lower river as well but they only had a few bites and no fish landed. Merwin Lake was still closed as of Wednesday. The launch was 2 or 3 feet out of the water and not useable unless you have a kayak. I suspect by this weekend that should change as the water is coming up, although just not very fast. Kayakers have been putting a hammer on the kokanee while the boats have been off the water with limits being had nearly every trip. Yale Lake has seemingly taken up the slack for boat anglers looking to get their limits of kokanee over the weekend, and while it wasn’t lights out fishing on Yale, most anglers left with their limits after a bit of a grind. Razor clamming is approved for this week, with really great tides starting on Friday all the way until Tuesday. I know Anglers Unlimited in Woodland just got a fresh stock of clamming guns and they won’t last long! Schedule: Thursday, 4 p.m.; -0.5 feet; Long Beach, Twin Harbors, Copalis Friday, 4:50 p.m.; -1.2 feet; Long Beach, Twin Harbors, Mocrocks Saturday, 5:36 p.m.; -1.6 feet; Long Beach, Twin Harbors, Mocrocks Sunday, 6:21 p.m.; -1.6 feet; Long Beach, Twin Harbors, Copalis Monday, 7:05 p.m.; -1.5 feet; Long Beach, Twin Harbors, Copalis Tuesday, 7:48 p.m.; -1.1 feet; Long Beach, Twin Harbors, Mocrocks Wednesday, 8:31 p.m.; -0.5 feet; Long Beach, Twin Harbors, Mocrocks Seth Kolshinski has been chasing steelhead and salmon in Southwest Washington since he can remember. Kolshinski uses his knowledge of year-round fishing from inland lakes to the coast to produce regular fishing forecasts for The Guide, a website launched in 1998 that offers fishing reports for Oregon and parts of Washington. Free reports like this one are available at www.theguidesforecast.com or people can become one of the 800 paid subscribers for more detailed reports. Sent weekly directly to your inbox!
The best ASX ETFs to unwrap this ChristmasNEW YORK (AP) – Investigators are searching for clues that could help them identify the masked gunman who stalked and killed the leader of one of the largest United States (US) health insurance companies on a Manhattan sidewalk, then disappeared into Central Park. UnitedHealthcare Chief Executive Officer Brian Thompson, 50, died in a dawn ambush on Wednesday as he walked to the company’s annual investor conference at a Hilton in Midtown, blocks from tourist draws like Radio City Music Hall and the Museum of Modern Art. The killing, and the shooter’s movements in the minutes before and afterward, were captured on some of the multitudes of security cameras present in that part of the city. One video showed him approach Thompson from behind, level his pistol and fire several shots, barely pausing to clear a brief gun jam while the dying health executive tumbled to the pavement. Other security cameras captured the initial stages of the gunman’s escape. He was seen fleeing the block across a pedestrian plaza, then escaping on a bicycle into Central Park, where he vanished. Police used drones, helicopters and dogs in an intense search, but the killer’s whereabouts remained unknown late into the night. New York City Police Commissioner Jessica Tisch said that while investigators had not yet established a motive, the shooting was no random act of violence. “Many people passed the suspect, but he appeared to wait for his intended target,” Tisch said at a news conference. “From watching the video, it does seem that he’s proficient in the use of firearms as he was able to clear the malfunctions pretty quickly,” NYPD Chief of Detectives Joseph Kenny said. Police issued several surveillance images of the man, who wore a hooded jacket and a mask that concealed most of his face and wouldn’t have attracted attention on a frigid winter day. Some of the photos were taken at a coffee shop shortly before the shooting. The police department offered a reward of up to USD10,000 for information leading to an arrest and conviction. “Brian was a highly respected colleague and friend to all who worked with him,” the insurer’s Minnetonka, Minnesota-based parent company, UnitedHealth Group Inc, said in a statement. “We are working closely with the New York Police Department and ask for your patience and understanding during this difficult time.” Thompson’s wife, Paulette Thompson, told NBC News that he told her “there were some people that had been threatening him”. She didn’t have details but suggested the threats may have involved issues with insurance coverage. The police chief in the Minneapolis suburb where Thompson lived Eric Werner said his department had not received any reports of threats against the executive. Investigators recovered several nine millimetre shell casings from outside the hotel and a cellphone from the alleyway through which the shooter fled. They were also searching Thompson’s hotel room, interviewing his UnitedHealthcare colleagues and reviewing his social media, Kenny said. Police initially said the shooter rode into Central Park on a bicycle from the city’s bike-share programme, CitiBike. But a spokesperson for the programme’s operator, Lyft, said police officials informed the company that the bike was not from the CitiBike fleet.Report: Institutional neutrality favored at Carolina, Wake, Duke
Adani FCPA Charges Show Scope of U.S. Laws for Indian Whistleblowers
The Miami Dolphins will not be activating Bradley Chubb by the deadline for Week 17, meaning he will not miss the entire 2024 season. Chubb had been working his way back from a torn ACL he suffered in Week 17 of the 2023 season. More news: Dolphins Could Face Browns Without David Njoku and QB in Potential Playoff Decider Dolphins LB Bradley Chubb will not be activated by tomorrow's deadline -- he is officially done for the season According to Marcel Louis-Jacques, "Dolphins LB Bradley Chubb will not be activated by tomorrow's deadline -- he is officially done for the season." The hope for Miami was that Chubb could have healed with enough time to make it back for a playoff push, but that will not be the case. Instead, the Dolphins will hold out hope that he will be ready to go by training camp in 2025. This is a devastating loss for the Dolphins, as Chubb was one of the best defensive ends during the 2023 season. Before his end-of-season injury, the star pass rusher secured 11 sacks and six forced fumbles. Sadly, Chubb suffered the ACL tear in the waning moments of Week 17 in 2023. Chubb joined Jaelan Phillips with a season-ending injury. Phillips suffered a torn Achilles in 2023 and also suffered a season-ending knee injury in 2024. Phillips had miraculously made it back to start the 2024 regular season, but that was short-lived. Following his Achilles tear, he suffered a knee injury that kept him out of most of the 2024 season. Chubb, on the other hand, did not get a chance to make his 2024 regular season debut. The star defender attempted to make it back the past couple of weeks, but will not be the case. Dolphins head coach Mike McDaniels spoke about Chubb missing the 2024 season. According to McDaniel , "Bradley takes that serious and has gone after the whole process so he can be Bradley Chubb for this team. He's been patient through this process. Ultimately, we all decided we didn't think he would be able to be the player he expects, we all expect. We need a little bit more time that unfortunately the season couldn't offer us. When he's on the field, everyone [will know] the player he is. Bradley Chubb wants to play football. Can he play to his standards?" More news: Packers Receive Massive Update on Severity of Christian Watson Injury The Dolphins are close to being eliminated from playoff contention, and it appears Miami is choosing to preserve Chubb for the 2024 season instead of activating him with chances of a postseason berth being so minimal. Miami would need to win its final two games against the Browns and Jets, while the Broncos or Chargers would need to lose their final two games. It is a long shot, and one that Chubb coming back while still recovering wouldn't have helped. For more on the Dolphins, head to Newsweek Sports .
70 Native American athletes set to play in Texas All-Star football game at The Star